Silence Therapeutics.

No events began in the chosen period. Widen it, or reset.

• Morgan Stanley Operational
  Bank of America and Morgan Stanley are restricting third-party AI agents amid cybersecurity scares and a declared bank run threat.
  Moves Silence Therapeutics

  Sun 13:24
• Merck Structural
  Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.
  Moves Silence Therapeutics

  Sun 12:39
• William P. Blair Operational
  William Blair cut Builders FirstSource's rating and Benchmark dropped its price target on the company.
  Moves Silence Therapeutics

  Sat 17:08
• FDA Structural
  FDA conducted surprise raids and inspections in Bihar state, directed by state government officials.
  Moves Silence Therapeutics

  Sun 14:06
• Securities and Exchange Commission Structural
  BlackRock filed disclosures with the SEC regarding the iShares 0-3 Month Treasury Bond ETF.
  Moves Silence Therapeutics

  Sun 13:31
• Cantor Fitzgerald Mentioned together
  The event reports that Brooke Rollins serves as Trump's Agriculture Secretary and notes that Lutnick previously ran Cantor Fitzgerald.
  Moves Silence Therapeutics

  Sun 14:13

• Merck Structural

  Merck acquired Silence Therapeutics, establishing a parent-subsidiary relationship.

  Some supportTue 12:31
  Silence Therapeutics → Merck

  Merck → Silence Therapeutics
• William P. Blair Operational

  William Blair actively influences the market perception and rating of Silence Therapeutics.

  Some supportTue 12:31
  Silence Therapeutics → William P. Blair

  William P. Blair → Silence Therapeutics
• Morgan Stanley Operational

  Morgan Stanley actively provides positive investment ratings and target price boosts for Silence Therapeutics.

  Well supportedThu 14:06
  Silence Therapeutics → Morgan Stanley

  Morgan Stanley → Silence Therapeutics
• FDA Structural

  Silence Therapeutics is seeking regulatory designations and approval from the FDA for its divesiran program.

  Some supportAug 10
  Silence Therapeutics → FDA

  FDA → Silence Therapeutics
• Securities and Exchange Commission Structural

  Silence Therapeutics is required to file disclosures with the Securities and Exchange Commission.

  Some supportJul 31
  Silence Therapeutics → Securities and Exchange Commission

  Securities and Exchange Commission → Silence Therapeutics
• Nasdaq Structural

  The company is listed on the Nasdaq stock exchange, relying on its market infrastructure for public trading.

  Some supportAug 10
  Silence Therapeutics → Nasdaq

  Nasdaq → Silence Therapeutics
• William Blair Mentioned together

  William Blair downgraded shares of Silence Therapeutics.

  Some supportThu 14:06
  Silence Therapeutics → William Blair

  William Blair → Silence Therapeutics
• Cantor Fitzgerald Mentioned together

  Cantor Fitzgerald provides financial coverage and issues ratings for Silence Therapeutics.

  Well supportedThu 14:06
  Silence Therapeutics → Cantor Fitzgerald

  Cantor Fitzgerald → Silence Therapeutics